151
Participants
Start Date
May 31, 2011
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
Fingolimod
0.5 mg in capsules for oral administration once daily
Interferon beta 1b
250 μg injected s.c. every other day
Novartis Investigative Site, Genova
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Gallarate
Novartis Investigative Site, Bergamo
Novartis Investigative Site, Montichiari
Novartis Investigative Site, Pavia
Novartis Investigative Site, Florence
Novartis Investigative Site, Ancona
Novartis Investigative Site, Alzenau in Unterfranken
Novartis Investigative Site, Chieti
Novartis Investigative Site, Bari
Novartis Investigative Site, Napoli
Novartis Investigative Site, Napoli
Novartis Investigative Site, Pozzilli
Novartis Investigative Site, Cefalù
Novartis Investigative Site, Catania
Novartis Investigative Site, Catania
Novartis Investigative Site, Bamberg
Novartis Investigative Site, Würzburg
Novartis Investigative Site, Messina
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY